131
Participants
Start Date
August 4, 2022
Primary Completion Date
May 10, 2024
Study Completion Date
May 10, 2024
GATT-Patch (currently named ETHIZIA)
"GATT-Patch (currently named ETHIZIA) is a sterile, flexible and resorbable hemostatic sealing patch. It presents as a blue, soft, flexible, porcine gelatin fiber-based carrier impregnated with an NHS-POx / NU-POx granulate. GATT-Patch measures 10 cm long by 5 cm wide. GATT-Patch is active and can be applied on both sides. Blue color is an aid to visualize GATT-Patch when applied onto a bleeding location.~GATT-Patch is indicated for use as an adjunct to hemostasis in surgery for minimal, mild or moderate bleeding sites when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical. GATT-Patch is intended to be used for management of hemorrhage during surgeries on the liver."
TachoSil
"TachoSil is a topical fibrin sealant patch consisting of human fibrinogen and human thrombin coated onto an equine collagen sponge.~TachoSil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery, when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical."
Weill-Cornell, New York
Atrium Health, Charlotte
Washington University, St Louis
Intermountain Healthcare, Murray
University of Southern California, Los Angeles
Rutgers University, Newark
Heidelberg University Hospital, Heidelberg
University Medical Center Groningen, Groningen
Radboud University Medical Center, Nijmegen
Erasmus MC, Rotterdam
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
GATT Technologies BV
INDUSTRY